摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-氨基联苯-2-甲酸 | 754166-77-3

中文名称
5-氨基联苯-2-甲酸
中文别名
——
英文名称
5-Amino-biphenyl-2-carboxylic acid
英文别名
4-amino-2-phenylbenzoic acid
5-氨基联苯-2-甲酸化学式
CAS
754166-77-3
化学式
C13H11NO2
mdl
——
分子量
213.23
InChiKey
KDPVECKHWIOFNR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    63.3
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • Aromatic Monoester Compositions and Processes for Preparing Same
    申请人:ExxonMobil Chemical Patents Inc.
    公开号:US20180282257A1
    公开(公告)日:2018-10-04
    This disclosure relates to compositions that include one or more aromatic monoesters derived from branched Guerbet alcohols and aromatic acids, or from branched Guerbet acids and aromatic alcohols. The compositions are suitable as lubricant base stocks.
    本披露涉及包含一种或多种从分支Guerbet醇和芳香酸或从分支Guerbet酸和芳香醇中衍生出的芳香单酯的组合物。这些组合物适用作润滑油基础油。
  • [EN] INHIBITORS OF PRENYL TRANSFERASES<br/>[FR] INHIBITEURS DES PRENYLE TRANSFERASES
    申请人:UNIVERSITY OF PITTSBURGH
    公开号:WO1996021456A1
    公开(公告)日:1996-07-18
    (EN) Compounds which inhibit prenyl transferases, particularly farnysyltransferase and geranylgeranyl transferase I, processes for preparing the compounds, pharmaceutical compositions containing the compounds, and methods of use.(FR) L'invention a pour objet des composés inhibiteurs des prényle transférases, particulièrement, des farnysyltransférases et des géranylgéranyle transférases I. L'invention traite également de procédés de préparations de ces composés, de compositions pharmaceutiques contenant ces composés et de leurs procédés d'utilisation.
    (EN) 抑制戊二烯转移酶,尤其是戊二烯基转移酶和戊二烯基转移酶I的化合物,制备这些化合物的方法,包含这些化合物的制药组合物以及使用方法。 (FR) 本发明涉及抑制戊二烯转移酶的化合物,尤其是戊二烯基转移酶和戊二烯基转移酶I的化合物,制备这些化合物的方法,包含这些化合物的制药组合物以及使用方法。
  • Compounds and methods for the inhibition of compounds cruzi
    申请人:Hamilton D Andrew
    公开号:US20060167269A1
    公开(公告)日:2006-07-27
    The present invention relates to compounds according to the formula (I): Where R A is a C 1 -C 10 substituted or unsubstituted linear, branch-chained or cyclic alkyl or alkenyl group or a phenyl group according to the formula (II): R B is a C 1 -C 10 substituted or unsubstituted linear, branch-chained or cyclic alkyl or alkenyl group or a phenyl group of the formula (III): R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are each independently selected from H, C 1 -C 10 (preferably a C 1 -C 4 ) alkyl or alkenyl group, CF 3 , F, Cl, Br, I, CN, NO 2 , NH 2 , NHR, NRR, COR (acyl group), OR (hydroxyl or ether group), CO 2 R (carboxylic acid or ester group), or COSR (thioester group) where R is H or a C 1 -C 10 (preferably a C 1 -C 4 ) alkyl or alkenyl group, an unsubstituted or substituted aryl (preferably, phenyl) or heterocycle group, or a (IV) group, where R 3 is H, a C 1 -C 10 (preferably a C 1 -C 4 ) alkyl, alkenyl, ether or a thioether group; and R 11 and R 12 are independently selected from H or a C 1 -C 3 alkyl or alkenyl group, or a pharmaceutically acceptable salt thereof and methods for treating infections caused by protozoal, fungal and/or bacterial agents such as Trypanosoma cruzi, Mycobacterium spp., Leishmania spp., Cryptococcus spp., Aspergillus spp., Histoplasma spp., Candida spp., especially Candida albicans, Pneumocystis carinii, Trichophyton spp., Microsporum spp., Malassezia spp., Rhizopus spp., Pseudallescheria spp., Blastomyces dermatitidis and Coccidiodes spp., among others.
    本发明涉及式(I)的化合物:其中RA是C1-C10取代或未取代的线性、支链或环烷基或烯基或式(II)的苯基:RB是C1-C10取代或未取代的线性、支链或环烷基或烯基或式(III)的苯基:R1、R2、R3、R4、R5、R6、R7、R8、R9和R10各自独立地选自H、C1-C10(优选为C1-C4)烷基或烯基、CF3、F、Cl、Br、I、CN、NO2、NH2、NHR、NRR、COR(酰基)、OR(羟基或醚基)、CO2R(羧酸或酯基)或COSR(酯基),其中R是H或C1-C10(优选为C1-C4)烷基或烯基、未取代或取代的芳基(优选为苯基)或杂环基,或式(IV)的基团,其中R3是H、C1-C10(优选为C1-C4)烷基、烯基、醚或醚基;R11和R12各自独立地选自H或C1-C3烷基或烯基,或其药学上可接受的盐,以及用于治疗由原虫、真菌和/或细菌引起的感染的方法,例如TrypanOSoma cruzi,Mycobacterium spp.,Leishmania spp.,Cryptococcus spp.,Aspergillus spp.,Histoplasma spp.,Candida spp.,特别是Candida albicans,Pneumocystis carinii,Trichophyton spp.,MicrOSporum spp.,Malassezia spp.,Rhizopus spp.,Pseudallescheria spp.,Blastomyces dermatitidis和Coccidioides spp.等。
  • Thermoplastic polyamideimide copolymers and method of preparation
    申请人:TORAY INDUSTRIES, INC.
    公开号:EP0017422A1
    公开(公告)日:1980-10-15
    Thermoplastic polyamideimide copolymers are provided which are excellent in both heat stability and melt viscosity characteristics at a temperature of from about 300°C to about 400°C. The copolymers of the invention comprise Units A of the formula in an amount of about 50 mole %, Units B of the formula in an amount of about 15-48 mole % and Units C of the formula in an amount of about 35-2 mole %, wherein Z is a trivalent aromatic group having two of its three carbonyl groups attached to adjacent carbon atoms, a is 0 or 1, b is 0,1,2,3 or 4, R1 is alkyl (C1-4), R2 is selected from alkyl (C1-4), halo and nitro, c is an integer from 1 to 25 and X is chosen from - SO2 -CO- or -C(CH3)2-. The copolymers may be made by reacting diamines containing the Units B and C respectively, e.g. I and II, with trimellitic acid (or another aromatic tribasic carboxylic acid with two carboxyl groups attached to adjacent carbon atoms) in an organic polar solvent using a dehydrating catalyst - or alternatively the diamines may be reacted with the acid anhydride acid chloride using a hydrochloride scavenger, subsequently closing the ring of the polyamide-amic acid thus formed.
    本发明提供的热塑性聚酰胺酰亚胺共聚物在约 300°C 至约 400°C 的温度条件下,热稳定性和熔融粘度特性都非常出色。 本发明的共聚物包含式中的单元 A,其含量约为 50 摩尔%;式中的单元 B,其含量约为 50 摩尔%。 约 50 摩尔%,式中单元 B 含量约为 15-48 摩尔%,以及式中的单元 C 其中 Z 是三价芳香基团,其三个羰基中的两个与相邻碳原子相连;a 是 0 或 1;b 是 0、1、2、3 或 4;R1 是烷基(C1-4);R2 选自烷基(C1-4)、卤代和硝基;c 是 1 至 25 的整数;X 选自-SO2-CO-或-C(CH3)2-。共聚物的制造方法是:使用脱催化剂,在有机极性溶剂中,将分别含有单元 B 和单元 C 的二胺(如 I 和 II)与偏苯三酸(或另一种在相邻碳原子上连接有两个羧基的芳香族三元羧酸)反应,或者使用盐酸盐清除剂,将二胺与酸酐酰反应,然后封闭由此形成的聚酰胺-氨基甲酸酯环。
  • Polymer modified adducts of epoxy resins and active hydrogen containing compounds containing mesogenic moieties
    申请人:THE DOW CHEMICAL COMPANY
    公开号:EP0469492A2
    公开(公告)日:1992-02-05
    Polymer modified adducts are prepared by (A) reacting (1) an epoxy resin having an average of more than one vicinal epoxide group with (2) a compound containing an average of two or more hydrogen atoms reactive with an epoxide group; and (B) partially vinylizing reacting the product from step (A); and (C) polymerizing the partially vinylized product from step (B) with (3) a polymerizable ethylenically unsaturated monomer; with the proviso that at least one of the components (1), (2) or (3) contain one or more mesogenic or rodlike moieties. These adducts are useful as epoxy resin curing agents.
    聚合物改性加合物的制备方法是:(A)将(1)具有平均一个以上副环氧基团的环氧树脂与(2)含有平均两个或两个以上与环氧基团反应的氢原子的化合物反应;以及(B)将步骤(A)的产物部分乙烯基化;(C) 将步骤(B)的部分乙烯基化产物与(3)可聚合的乙烯基不饱和单体聚合;但条件是组分(1)、(2)或(3)中至少有一种含有一个或多个介原或棒状分子。这些加合物可用作环氧树脂固化剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫